CD274 and neoplasm: Despite the lack of clinical correlation and PD-L1 expression of the tumour, the high prevalence of PD-L1 positivity in HRS cells and APCs gives hope for new therapeutic possibilities targeting the programmed death pathway in these patients because although modern therapeutic protocols have high success rates, an important portion of the patients still cannot achieve complete remission or relapses still occur.